Developer docs
API playgroundTry for free, no card

Search company profiles

Labtech Diagnostics

Full company profile

uuid000huce

Namestring
Labtech Diagnostics
Legal namestring
Labtech
Company typeenum
Private
Founded yearint
2019
Descriptiontext

Per source-attributed data, the entity referenced as "Labtech" was not a legitimate operating diagnostic business. It was established in March 2019 as one of multiple shell companies — alongside Chateau d'Lumina Hospice and Palliative Care, Saint Gorge Radiology, Hope Diagnostics, Direct Imaging & Diagnostics, Lab One, and Lifescan Diagnostics — controlled by Sophia Shaklian (Larchmont, Los Angeles) to submit fraudulent Medicare claims for unnecessary or undelivered diagnostic testing services. The fraudulent scheme operated from March 2019 through August 2024, defrauding Medicare of more than $14 million. There is no documented product, proprietary technology, operational workflow, or business model; the entity functioned purely as a billing vehicle within a coordinated fraud network.

On 2026-03-25, Sophia Shaklian was sentenced to 35 months in federal prison and ordered to pay $14,103,043 in restitution. Co-defendant Alex Alexsanian pleaded guilty to money laundering conspiracy. The entity's operating status is documented as "closed" as of August 2024. No management team, products, services, certifications, integrations, or technology stack are recorded in the source data.

A separate unsourced firmographic snapshot references a "Labtech Diagnostics" founded in 2011, based in Anderson, US, with 51-100 employees, providing diagnostic services to patients, physicians, and other healthcare providers. This profile lacks a source ID, conflicts with the detailed source-attributed fraud-case profile on founding year (2011 vs. 2019), geography (Anderson vs. Los Angeles), and operating status (active vs. closed), and is not corroborated by any other data. It may describe a distinct entity with a similar name, but no defensible source-attributed information is available to characterize its business model, products, or customer base.

Short descriptiontext

Source-attributed records describe Labtech as a shell company controlled by Sophia Shaklian and used, alongside related entities, to submit fraudulent Medicare claims for diagnostic testing from March 2019 through August 2024; the entity is closed and Shaklian was sentenced in March 2026.

Operating statusenum
Closed
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersAnderson, United States
HQ citystring
Anderson
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
diagnostic testing services, clinical laboratory services, medical diagnostic testing, patient diagnostic services, healthcare laboratory diagnostics
Industry1 code
PRIMARYHLAFAMAJ
Reference & Esoteric Testing Laboratories
NAICS code1 code
  • Medical Laboratories621511
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Clinical Diagnostic Laboratory Services
Cost components3 values
Personnel, Operations, Technology or R&D
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Labtech Diagnostics provides diagnostic services to patients, physicians, and other health care providers. The company operates as a clinical laboratory offering diagnostic testing services, based in Anderson, United States, founded in 2011 with 51-100 employees.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Clinical Diagnostic Testing Services
Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Peers8 records
TypeBroad incumbent
Description

Largest U.S. independent clinical laboratory network providing routine and esoteric diagnostic testing to physicians, hospitals, and patients. Comparable as the canonical reference lab business model — the same customer/production economics Labtech Diagnostics nominally served in its firmographic self-description.

TypeEmerging player
Description

Commercial-stage diagnostics company known for Cologuard colorectal cancer screening and oncologic liquid biopsy. Comparable as a clinical-revenue diagnostics lab serving physician-ordered testing.

TypeDirect peer
Description

National reference laboratory affiliated with the University of Utah, offering esoteric and routine clinical testing to hospitals and physicians. Closely aligned with a reference/esoteric testing lab business model.

TypeDirect peer
Description

Full-service clinical diagnostics laboratory focused on esoteric testing, women's health, oncology, and urology. Comparable mid-sized reference lab competing for the same specialty-diagnostic, physician-office channel that Labtech targeted.

TypeDirect peer
Description

Reference laboratory extending Mayo Clinic's diagnostic capabilities to outside hospitals and health systems nationwide. Representative of the high-complexity, esoteric-testing reference lab archetype.

TypeBroad incumbent
Description

International diagnostics provider with significant U.S. footprint (via American Esoteric Laboratories, Clinical Pathology Laboratories, etc.). Comparable as a multi-state reference lab operator serving physicians and hospitals.

TypeEmerging player
Description

Specialized diagnostics company focused on cell-free DNA testing in reproductive health, oncology, and organ transplant. Comparable as a specialty diagnostics lab operating in the physician-referral channel.

TypeBroad incumbent
Description

Major U.S. clinical lab network offering diagnostic testing, specialty testing, and routine lab services to physicians, employers, and patients. Closest direct functional competitor in the outpatient diagnostic lab category that Labtech claimed to serve.

Market position
Strengths1 record

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights2 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Labtech Diagnostics

Clinical Diagnostic Laboratory Serviceslabtechdiagnostics.net

Source-attributed records describe Labtech as a shell company controlled by Sophia Shaklian and used, alongside related entities, to submit fraudulent Medicare claims for diagnostic testing from March 2019 through August 2024; the entity is closed and Shaklian was sentenced in March 2026.

What Labtech Diagnostics does

Per source-attributed data, the entity referenced as "Labtech" was not a legitimate operating diagnostic business. It was established in March 2019 as one of multiple shell companies — alongside Chateau d'Lumina Hospice and Palliative Care, Saint Gorge Radiology, Hope Diagnostics, Direct Imaging & Diagnostics, Lab One, and Lifescan Diagnostics — controlled by Sophia Shaklian (Larchmont, Los Angeles) to submit fraudulent Medicare claims for unnecessary or undelivered diagnostic testing services. The fraudulent scheme operated from March 2019 through August 2024, defrauding Medicare of more than $14 million. There is no documented product, proprietary technology, operational workflow, or business model; the entity functioned purely as a billing vehicle within a coordinated fraud network.

On 2026-03-25, Sophia Shaklian was sentenced to 35 months in federal prison and ordered to pay $14,103,043 in restitution. Co-defendant Alex Alexsanian pleaded guilty to money laundering conspiracy. The entity's operating status is documented as "closed" as of August 2024. No management team, products, services, certifications, integrations, or technology stack are recorded in the source data.

A separate unsourced firmographic snapshot references a "Labtech Diagnostics" founded in 2011, based in Anderson, US, with 51-100 employees, providing diagnostic services to patients, physicians, and other healthcare providers. This profile lacks a source ID, conflicts with the detailed source-attributed fraud-case profile on founding year (2011 vs. 2019), geography (Anderson vs. Los Angeles), and operating status (active vs. closed), and is not corroborated by any other data. It may describe a distinct entity with a similar name, but no defensible source-attributed information is available to characterize its business model, products, or customer base.

Labtech Diagnostics firmographics

Firmographics
Name
Labtech Diagnostics
Legal name
Labtech
Website
https://labtechdiagnostics.net
Company type
Private
Founded year
2019
Operating status
Closed
Headcount range
11–50 employees
Short description
Source-attributed records describe Labtech as a shell company controlled by Sophia Shaklian and used, alongside related entities, to submit fraudulent Medicare claims for diagnostic testing from March 2019 through August 2024; the entity is closed and Shaklian was sentenced in March 2026.
Ownership category
akta.pro rank

Labtech Diagnostics industry classification

Industry
Product category
Clinical Diagnostic Laboratory Services
NAICS
Medical Laboratories (621511)
SIC
Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAFAMAJ
Reference & Esoteric Testing Laboratories

Keywords

  • Diagnostic testing services
  • Clinical laboratory services
  • Medical diagnostic testing
  • Patient diagnostic services
  • Healthcare laboratory diagnostics

Where Labtech Diagnostics is headquartered

Location

Headquarters

HQ city
Anderson
HQ country
United States
HQ region
North America

Markets served

Labtech Diagnostics business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D

Labtech Diagnostics product offering

Product offering

Core offering

Labtech Diagnostics provides diagnostic services to patients, physicians, and other health care providers. The company operates as a clinical laboratory offering diagnostic testing services, based in Anderson, United States, founded in 2011 with 51-100 employees.

Differentiator

Problem solved

Functional benefit

Products and services

  • Clinical Diagnostic Testing Services

Companies that use Labtech Diagnostics

Customer profile

Ideal customer profiles2 records

Labtech Diagnostics technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Labtech Diagnostics partnerships and signals

Strategic signal

Recent moves3 records

Labtech Diagnostics competitors and assessment

Company assessment

Broad incumbents

  • Quest Diagnostics: Largest U.S. independent clinical laboratory network providing routine and esoteric diagnostic testing to physicians, hospitals, and patients. Comparable as the canonical reference lab business model — the same customer/production economics Labtech Diagnostics nominally served in its firmographic self-description.
  • Sonic Healthcare USA: International diagnostics provider with significant U.S. footprint (via American Esoteric Laboratories, Clinical Pathology Laboratories, etc.). Comparable as a multi-state reference lab operator serving physicians and hospitals.
  • Laboratory Corporation of America (Labcorp): Major U.S. clinical lab network offering diagnostic testing, specialty testing, and routine lab services to physicians, employers, and patients. Closest direct functional competitor in the outpatient diagnostic lab category that Labtech claimed to serve.

Emerging players

  • Exact Sciences: Commercial-stage diagnostics company known for Cologuard colorectal cancer screening and oncologic liquid biopsy. Comparable as a clinical-revenue diagnostics lab serving physician-ordered testing.
  • Natera: Specialized diagnostics company focused on cell-free DNA testing in reproductive health, oncology, and organ transplant. Comparable as a specialty diagnostics lab operating in the physician-referral channel.

Direct peers

  • ARUP Laboratories: National reference laboratory affiliated with the University of Utah, offering esoteric and routine clinical testing to hospitals and physicians. Closely aligned with a reference/esoteric testing lab business model.
  • BioReference Laboratories: Full-service clinical diagnostics laboratory focused on esoteric testing, women's health, oncology, and urology. Comparable mid-sized reference lab competing for the same specialty-diagnostic, physician-office channel that Labtech targeted.
  • Mayo Clinic Laboratories: Reference laboratory extending Mayo Clinic's diagnostic capabilities to outside hospitals and health systems nationwide. Representative of the high-complexity, esoteric-testing reference lab archetype.

Market position

Strengths1 record

Weaknesses4 records

Competitive moat2 records

Key risks6 records

Key highlights2 records

Customer concentration

Labtech Diagnostics social profiles

Digital presence

Labtech Diagnostics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Labtech Diagnostics leadership team

Management profile

Number of profiles

Labtech Diagnostics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Labtech Diagnostics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Labtech Diagnostics

What does Labtech Diagnostics do?

Labtech Diagnostics provides diagnostic services to patients, physicians, and other health care providers. The company operates as a clinical laboratory offering diagnostic testing services, based in Anderson, United States, founded in 2011 with 51-100 employees.

Is Labtech Diagnostics a public or private company?

Labtech Diagnostics is a private company. It is classified as unknown and is currently closed.

When was Labtech Diagnostics founded?

Labtech Diagnostics was founded in 2019. It employs 11 to 50 people.

Where is Labtech Diagnostics based?

Labtech Diagnostics is headquartered in Anderson, United States, in the North America region.

Who are Labtech Diagnostics's main competitors?

Broad incumbents on record are Quest Diagnostics, Sonic Healthcare USA and Laboratory Corporation of America (Labcorp). Emerging players are Exact Sciences and Natera. Direct peers are ARUP Laboratories, BioReference Laboratories and Mayo Clinic Laboratories.

Does Labtech Diagnostics have an API?

No public API is recorded for Labtech Diagnostics.

What industry is Labtech Diagnostics in?

Labtech Diagnostics's product category is Clinical Diagnostic Laboratory Services. Its primary akta.pro industry code is HLAFAMAJ, Reference & Esoteric Testing Laboratories. Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EdhatLarchmont Woman Sentenced to Nearly 3 Years in Prison For Her Role in Hospice and Diagnostic Testing Fraud that Conned MedicareSophia Shaklian, 38, of Larchmont, Los Angeles, was sentenced to 35 months in federal prison for healthcare fraud after defrauding Medicare of more than $14 million through fraudulent hospice care and diagnostic testing claims submitted between March 2019 and August 2024. Shaklian owned multiple shell companies including Chateau d'Lumina Hospice and Palliative Care, Saint Gorge Radiology, Hope Diagnostics, Direct Imaging & Diagnostics, Lab One, Labtech, and Lifescan Diagnostics, which she used to submit claims for services that were either unnecessary or never provided to Medicare beneficiaries. She was ordered to pay $14,103,043 in restitution, and co-defendant Alex Alexsanian pleaded guilty to money laundering conspiracy charges.https://www.foxcarolina.comAnderson laboratory agrees to pay millions to settle allegations of kickbacks to doctorsClinical Laboratory LTD Holding LLC, formerly Labtech Diagnostics LLC, agreed to pay at least $6.8 million to resolve False Claims Act allegations involving illegal kickbacks to doctors for laboratory testing referrals. The company and its CEO pleaded guilty to five counts of violating the Anti-Kickback Statute by disguising payments as office space rental, phlebotomy, and toxicology services between 2016 and 2021.PR NewswireQuest Diagnostics Acquires South Carolina-based Labtech DiagnosticsQuest Diagnostics has acquired substantially all assets of Labtech Diagnostics, an independent clinical diagnostic laboratory provider operating in the Southeastern United States. This acquisition marks Quest's first full-service laboratory ownership in South Carolina and supports its broader growth strategy in the region by expanding access to diagnostic services for physicians and patients.Mpo-magQuest Diagnostics Buys Labtech DiagnosticsQuest Diagnostics has acquired substantially all assets of Labtech Diagnostics, an independent clinical diagnostic laboratory provider operating primarily in the Southeastern United States. This acquisition integrates Labtech's facilities, including its Anderson, South Carolina location, into Quest's national network to expand diagnostic access and support its regional growth strategy.